A coalition of some of Canada’s biggest media companies is seeking billions of dollars in compensation for what they say is copyright infringement on their work through ChatGPT.
Tag: Intellectual Property
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Paraguay Loves Mickey, the Cartoon Mouse. Disney Doesn’t.
Mickey, a homegrown food-packaging company, is famous for facing down Disney in Paraguay’s Supreme Court. As the family business turns 90, why is it still so popular?
Microsoft Makes High-Stakes Play in Tech Cold War With Emirati A.I. Deal
Microsoft said it would invest $1.5 billion in G42, an Emirati company with ties to China, as Washington and Beijing maneuver to secure tech influence in the Persian Gulf.
Indigenous Authors and the Challenge of Telling Their Own Story
A university program seeks to improve cross-cultural understanding in Australia’s publishing industry.
Her Instagram Handle Was ‘Metaverse.’ Last Month, It Vanished.
Five days after Facebook changed its name to Meta, an Australian artist found herself blocked, with seemingly no recourse, from an account documenting nearly a decade of her life and work.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
As U.S. Hunts for Chinese Spies, University Scientists Warn of Backlash
A chilling effect has taken hold on American campuses, contributing to an outflow of academic talent that may hurt the United States while benefiting Beijing.
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.